Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard (Q42030543)

15 October 2017

Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard (English)

1 reference

15 October 2017

1 reference

2

1 reference

15 October 2017

Neus Martínez-Bosch

1

1 reference

15 October 2017

3 August 2014

1 reference

15 October 2017

1 reference

15 October 2017

3

1 reference

15 October 2017

8

1 reference

15 October 2017

e952201

1 reference

Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Unraveling galectin-1 as a novel therapeutic target for cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

The immune network in pancreatic cancer development and progression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292238

High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer

5 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25610742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/21624011.2014.952201

1 reference

15 October 2017

1 reference

15 October 2017

1 reference

PMCID

4292238